Welcome to PritzkerOlsen, P.A.

Bayer Lawsuit - Trasylol, Kidney Failure and Death

URGENT WARNING REGARDING TRASYLOL AND BAYER LAWSUIT INFORMATION: Due to possible increased risk for death and serious adverse events, Bayer has pulled Trasylol, a drug used to control bleeding during heart surgery, from the U.S. market. The information below on Bayer and Trasylol is provided by Pritzker | Olsen, P.A., a nationally-recognized law firm with extensive experience representing people with kidney damage. The firm is actively investigating cases involving kidney damage and the use of Trasylol. The firm has a national reputation, and attorneys at the firm have been interviewed by The New York Times, The Wall Street Journal, Lawyers USA and other publications. Fred Pritzker, Elliot Olsen and Eric Hageman have been named "Super Lawyers" by Law & Politics magazine. To contact a lawyer at the firm about the Trasylol recall, Trasylol kidney damage and a Bayer lawsuit, please call toll-free at 1-888-377-8900, e-mail our attorneys (Fred Pritzker is managing attorney for the Trasylol cases), or submit the firm's free case consultation form.

Bayer Agrees to Marketing Suspension
of Trasylol (Trasylol "Recall")

On Nov. 5, 2007, the U.S. Food and Drug Administration announced that Bayer Pharmaceuticals Corp. agreed to an FDA-requested marketing suspension of Trasylol. Trasylol is an antifibrinolytic drug approved to reduce blood loss during surgery and the need for blood transfusion in certain patient undergoing cardiopulmonary bypass in the course of coronary artery bypass graft surgery. Antifibrinolyitc drugs help slow the breakdown of blood clots and subsequent excessive bleeding.

At the time of the marketing suspension, preliminary results from a Canadian study suggested an increased risk for kidney failure and death compared to two other drugs used to control bleeding.

Bayer Removes Trasylol from U.S. Market

On May 16, 2008, the FDA announced that Bayer HealthCare Pharmaceuticals Inc. had notified the FDA that the company would begin removing the remaining Trasylol stock from the U.S. market, most of which was in warehouses and hospital or physician’s stock at the time of the announcement.

Bayer and the FDA worked out a limited use agreement regarding Trasylol, under which access to Trasylol is limited to investigational use of the drug according to the procedures described in a special treatment protocol. The protocol allows treatment for certain patients who are at increased risk of blood loss and transfusions during coronary artery bypass graft surgery and who have no acceptable alternative therapy. Physicians using Trasylol in this situation must also verify that the benefits of the drug clearly outweigh the risks for their patients.

FDA limits access to certain drugs to patients with serious or immediately life-threatening disease or conditions who lack other therapeutic options and may benefit from such therapies. This type of access requires the submission of a protocol, which is reviewed and approved by the agency. Bayer has agreed to provide Trasylol through this mechanism for the limited use described above.

If you or a loved one has had a serious adverse event (including kidney failure or death) associated with the administration of Trasylol, please contact our law firm for Bayer lawsuit information.  To contact the firm, please call 1-888-377-8900 (toll-free), e-mail our lawyers or submit the firm’s free, online case consultation form.

Keywords: Bayer Lawsuit, Bayer Class Action, Lawsuit against Bayer, Trasylol

 


 


Free Case Consultation





Logos

Firm News

Fred Pritzker Listed in The Best Lawyers in America

Fred Pritzker has been notified that he will again be listed in The Best Lawyers in America for his work in personal injury litigation.

 

Attorney Elliot Olsen Speaks at Conference

Attorney Elliot Olsen recently spoke at the Seventh Annual LifeScience Alley Conference in Minneapolis on Preemption and the Future of Medical Device Litigation.  He appeared with Randall Pattee of Lindquist and Vennum and Jean Lance, VP of corporate legal and general counsel for Boston Scientific. 

 

ADHD Medication and Cardiac Death

ADHD Medications that may be associated with sudden death in healthy children, according to the FDA: Focalin, Focalin...

 

Zicam Lawsuits

On June 16, 2009 FDA altered consumers to the risk of anosmia (loss of smell) with the use of certain Zicam products marketed by Matrixx Initiatives. ...

 

Denture Cream Lawsuit

Denture users throughout the nation are suing denture cream manufacturers Proctor & Gamble Co. and GlaxoSmithKline PLC, alleging that Fixodent ...

 

Super PoliGrip Lawsuit

People who use dentures should be aware that lawsuits have been filed alleging that use of PoliGrip and other denture creams caused zinc poisoning, wh...

 

Medtronic Recall and Medtronic Lawsuit

FDA has annonced a Medtronic Spring Fidelis defibrillator lead recall. Two of our clients with defective Medtronic leads were shocked over twenty times before medical professionals were able to turn off the defibrillator.

 

Fleet Lawsuit

We are representing several people who experienced kidney failure (acute phosphate nephropathy) after use of Fleet Phospho-soda solution or Fleet Accu-Prep solution for bowel cleansing.

 

Ortho Evra Lawsuit: Ortho Evra Birth Control Patch

The Ortho Evra birth control patch has been linked to an increased risk of blood clots that can lead to pulmonary embolism, stroke and heart attack.

 

Trasylol Recall

Bayer has agreed to a marketing suspension of Trasylol, a drug used to control bleeding during heart surgery, pending detailed review of preliminary results from a Canadian study that suggested an increased risk for death.

 

Fentanyl Lawsuit and Fentanyl Recall

There have been a number of recalls regarding fentanyl due to the risk of a fentanyl overdose.

 

Fosamax and Osteonecrosis

Several cases of bisphosphonate-associated osteonecrosis of the jaw have been associated with the use of oral bisphosphonates, including Fosamax®, Actonel®, and other medications. 

 

NuvaRing Death

Lawsuits have been filed alleging death and serious injury associated with NuvaRing, a contraceptive product make by Organon. Contact us about NuvaRing stroke, NuvaRing pulmonary embolism, NuvaRing heart attack, and an Organon NuvaRing lawsuit.